Keywords: Pfizer, Third quarter 2009 results, Financial
Pfizer 2009 3rd-qtr earnings beats forecasts, but sales weaken
Article | 21 October 2009
Global pharmaceutical behemoth Pfizer reported higher third-quarter 2009 profit as aggressive cost-cutting offset a negative foreign exchange impact and declining sales ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Elan makes "transformational" acquisitions and a divestment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- New study shows UCB's Neupro reduces NSBP in RLS patient
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
